Back to Search
DEBORAH HACKETT, M.D.
M.D.
Endocrinology, Diabetes & Metabolism Physician
NPI: 1821028903Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
56313701205(UT)
Research & Publications (20)
Potassium dichromate induced cytotoxicity, genotoxicity and oxidative stress in human liver carcinoma (HepG2) cells.
PMID 19440407·Int J Environ Res Public Health·2009
8-other
Outcomes of elderly patients aged 80 and over with symptomatic, severe aortic stenosis: impact of patient's choice of refusing aortic valve replacement on survival.
PMID 18443003·QJM·2008
8-other
Role of non-invasive imaging in the management of coronary artery disease: an assessment of likely change over the next 10 years. A report from the British Cardiovascular Society Working Group.
PMID 17401065·Heart·2007
6-review
Estimation of symptom-free days in generalized anxiety disorder.
PMID 16574041·Curr Med Res Opin·2006
8-other
Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor alpha-difluoromethylornithine (DFMO) in human breast cancer cells.
PMID 15672871·Clin Exp Metastasis·2004
8-other
Impact of gastrointestinal symptom severity on response to venlafaxine extended-release in patients with generalized anxiety disorder.
PMID 15291662·J Clin Psychiatry·2004
4-observational
Social adjustment in generalised anxiety disorder: a long-term placebo-controlled study of venlafaxine extended release.
PMID 15276659·Eur Psychiatry·2004
3-trial
Venlafaxine versus placebo in the preventive treatment of recurrent major depression.
PMID 15096071·J Clin Psychiatry·2004
3-trial
Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder.
PMID 15022148·Depress Anxiety·2004
3-trial
Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies.
PMID 12826987·J Clin Psychopharmacol·2003
8-other
A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder.
PMID 12814852·Eur Psychiatry·2003
3-trial
Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysis.
PMID 12454555·J Clin Psychopharmacol·2002
3-trial
Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.
PMID 12409680·Int Clin Psychopharmacol·2002
3-trial
Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
PMID 12203668·Depress Anxiety·2002
4-observational
Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.
PMID 12028242·J Am Geriatr Soc·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4403 HARRISON BLVD, STE 3630
OGDEN, UT 84403 - Phone
- (801) 387-7900
Quick Facts
- NPI
- 1821028903
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile